Scleroderma Clinical Trials Scleroderma RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study of the Efficiency And Safety Study of Belimumab Compared To Placebo In Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Condition:   Systemic Sclerosis Associated Interstitial Lung Disease Interventions:   Biological: Belimumab;   Other: Placebo Sponsor:   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2023 Category: Research Source Type: clinical trials